Literature DB >> 28986722

Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Māori women.

Megan A Smith1,2, Simon Edwards3, Karen Canfell4,3.   

Abstract

BACKGROUND: New Zealand is an example of a country with a well-established cytology-based screening program. New Zealand's National Cervical Screening Programme (NCSP) commenced in 1990, and recommends three-yearly cytology-based screening for women aged 20-69 years. In 2018, the NCSP will transition to five-yearly HPV-based screening for women aged 25-69 years. The aim of this study was to assess the impact of the program to date in different groups, to provide a benchmark for the new program.
METHODS: Analysis of cervical cancer trends in New Zealand by age and ethnicity over the period 1985-2013, and by morphology over the period 1997-2013, using data from the New Zealand Cancer Registry was conducted.
RESULTS: The overall incidence of cervical cancer was 56% (95% CI 51-60%) lower in 2009-2013 than in 1985-1989, and significant reductions were observed in women aged 25-49, 50-69, and 70 + years. Relative reductions in cervical cancer were very similar for Māori and non-Māori women aged 25-49 (50% in Māori; 52% in non-Māori) and 50-69 years (65% in Māori; 69% in non-Māori). In contrast, incidence appeared to increase after around 1996 in women aged 20-24. The increasing trend was significant for women aged 20-24 overall and for non-Māori women (p < 0.01 in both cases).
CONCLUSION: There have been substantial reductions in cervical cancer among women aged 25 + years in New Zealand since the inception of the NCSP, and these reductions are similar in Māori and non-Māori women. Cervical cancer incidence among women 20-24 years has not declined since the NCSP began, and appears to be increasing.

Entities:  

Keywords:  Cancer trends; Cervical cancer; Ethnicity; Health disparities; New Zealand; Screening

Mesh:

Year:  2017        PMID: 28986722     DOI: 10.1007/s10552-017-0967-y

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  4 in total

Review 1.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.

Authors:  Sarah Gupta; Christina Palmer; Elisabeth M Bik; Juan P Cardenas; Harold Nuñez; Laurens Kraal; Sara W Bird; Jennie Bowers; Alison Smith; Nathaniel A Walton; Audrey D Goddard; Daniel E Almonacid; Susan Zneimer; Jessica Richman; Zachary S Apte
Journal:  Front Public Health       Date:  2018-04-09

2.  Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint.

Authors:  Lina Yin; Saiquan Lu; Jun Zhu; Weiling Zhang; Guihao Ke
Journal:  Radiat Oncol       Date:  2019-06-10       Impact factor: 3.481

3.  Ethnic Differences in Cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018.

Authors:  Dahai Yu; Zheng Wang; Yamei Cai; Kate McBride; Uchechukwu Levi Osuagwu; Karen Pickering; John Baker; Richard Cutfield; Brandon J Orr-Walker; Gerhard Sundborn; Michael B Jameson; Zhanzheng Zhao; David Simmons
Journal:  JAMA Netw Open       Date:  2022-02-01

4.  Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.

Authors:  David Robert Grimes; Edward M A Corry; Talía Malagón; Ciaran O'Riain; Eduardo L Franco; Donal J Brennan
Journal:  JAMA Netw Open       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.